Type 2 diabetes (T2D) patients with co-morbid fatty liver disease who undergo gastric bypass surgery are more likely to experience long-term diabetes remission than are T2D patients without fatty liver, according to a large retrospective analysis by Cleveland Clinic researchers.
Patients with gastric bypass surgery have an altered anatomy that can make it difficult for physicians to treat problems in the pancreas or bile duct.
Cleveland Clinic is co-directing a newly launched NIH clinical trial that aims to better understand — and potentially target — the mind and body factors behind suboptimal bariatric surgery outcomes.
Watch Cleveland Clinic surgeon Philip Schauer, MD, demonstrate laparoscopic Roux-en-Y gastric bypass. He walks viewers through the essential steps, including jejunojejunostomy and gastrojejunostomy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
At AACE Cleveland Clinic researchers presented results of a study comparing pre- and post-operative insulin regimens and dosages in patients with T2D who had undergone gastric bypass.
Cleveland Clinic study finds gastric bypass surgery is a viable option for obese patients and should be considered early in the course of type 2 diabetes treatment.